Report cover image

Global Isocitrate Lyase (ICL) Activity Assay Kit Market Growth 2025-2031

Published Jun 09, 2025
Length 128 Pages
SKU # LPI20070320

Description

The global Isocitrate Lyase (ICL) Activity Assay Kit market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Isocitrate lyase (ICL) mainly exists in plants and microorganisms. During the germination of oil crop seeds, fats are converted into carbohydrates through the glyoxylate cycle and other processes. ICL is one of the key enzymes of the glyoxylate cycle. ICL catalyzes the degradation of isocitric acid into glyoxylic acid and succinic acid. Glyoxylic acid and NADH generate ethanol and NAD under the action of LDH. NADH has a characteristic absorption peak at 340nm. Monitoring the decrease rate of absorbance at 340nm can indirectly reflect the activity of ICL .

United States market for Isocitrate Lyase (ICL) Activity Assay Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Isocitrate Lyase (ICL) Activity Assay Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Isocitrate Lyase (ICL) Activity Assay Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Isocitrate Lyase (ICL) Activity Assay Kit players cover Abcam, Elabscience, Biohippo, Abnova, Aviva Systems Biology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Isocitrate Lyase (ICL) Activity Assay Kit Industry Forecast” looks at past sales and reviews total world Isocitrate Lyase (ICL) Activity Assay Kit sales in 2024, providing a comprehensive analysis by region and market sector of projected Isocitrate Lyase (ICL) Activity Assay Kit sales for 2025 through 2031. With Isocitrate Lyase (ICL) Activity Assay Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Isocitrate Lyase (ICL) Activity Assay Kit industry.

This Insight Report provides a comprehensive analysis of the global Isocitrate Lyase (ICL) Activity Assay Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Isocitrate Lyase (ICL) Activity Assay Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Isocitrate Lyase (ICL) Activity Assay Kit market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Isocitrate Lyase (ICL) Activity Assay Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Isocitrate Lyase (ICL) Activity Assay Kit.

This report presents a comprehensive overview, market shares, and growth opportunities of Isocitrate Lyase (ICL) Activity Assay Kit market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Spectrophotometry Method
ELISA Method
Others

Segmentation by Application:
Academic Research Institution
Hospitals And Diagnostic Centers
Biopharmaceutical
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abcam
Elabscience
Biohippo
Abnova
Aviva Systems Biology
BPS Bioscience
Sigma-Aldrich
Real-Gene Labs
Sunlong Biotech
BOXBIO
Shanghai Enzyme Linked Biotechnology
Shanghai Zhili Biotechnology
Shanghai TW-Reagent
Shanghai Lmai Bioengineering
Shanghai Xinfan Biotechnology
Beijing Solarbio Science & Technology
Shanghai Hailing Biotechnology
Shanghai Sig Biotechnology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Isocitrate Lyase (ICL) Activity Assay Kit market?

What factors are driving Isocitrate Lyase (ICL) Activity Assay Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Isocitrate Lyase (ICL) Activity Assay Kit market opportunities vary by end market size?

How does Isocitrate Lyase (ICL) Activity Assay Kit break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

128 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Isocitrate Lyase (ICL) Activity Assay Kit by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Isocitrate Lyase (ICL) Activity Assay Kit by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.